# A Phase I In-Vivo Peptide Applied in the Right Colon

> **NCT01722058** · PHASE1 · COMPLETED · sponsor: **University of Michigan** · enrollment: 25 (actual)

## Conditions studied

- Colon Lesions

## Interventions

- **DRUG:** Peptide application

## Key facts

- **NCT ID:** NCT01722058
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2013-06
- **Final completion:** 2013-08
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2013-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01722058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01722058, "A Phase I In-Vivo Peptide Applied in the Right Colon". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT01722058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*